Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCTs051250121) titled 'A study evaluating the efficacy of combination therapy with Ninjin'yoeito and anamorelin in patients with gastrointestinal cancers' on Sept. 29.
Study Type: Interventional
Study Design:
randomized controlled trial, open(masking not used), active control, parallel assignment, treatment purpose
Primary Sponsor: YAMAGUCHI Toshifumi
Condition:
Gastrointestinal cancers (gastric cancer, pancreatic cancer, colorectal cancer) with cancer cachexia
Intervention:
Ninjin'yoeito, anamorelin
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 29/09/2025
Target Sample Size: 44
To know more, ...